Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients

 
 

  Scholarships Awarded to Nine Students Affected by Dermatologic Conditions  

 

Bausch Health Companies Inc. (NYSETSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the recipients of their 2021 Aspire Higher scholarship program. The program, which began in 2012, will award nine students who have been treated for a dermatologic condition with a scholarship of up to $10,000 to pursue their undergraduate or graduate degrees.

 

"For nine years, Ortho Dermatologics has supported students in achieving their higher education goals through our Aspire Higher scholarship program. Beyond the demands of their schooling and extracurricular activities, these students have also had to manage the burden of living with a skin condition," said Scott Hirsch , senior vice president and chief strategy officer, Bausch Health, and president, Ortho Dermatologics. "The stories our 2021 scholarship recipients shared with us are inspiring, and we are honored to provide them with this award to recognize their achievements and help them pursue their academic aspirations."

 

The 2021 honorees were chosen from nearly 150 applications and were selected in part due to their essays overviewing their educational journeys while living with dermatologic conditions and the role a health care professional played in treating the condition. The applications were judged by an independent panel of dermatologists from across the country.

 

The Aspire Higher scholarship program recognizes students across a wide range of educational pursuits, with scholarships in three categories, including the Undergraduate Scholar Awards, the Graduate Scholar Awards, and the Today's Woman Scholar Awards for mothers pursuing undergraduate or graduate degrees.

 

The 2021 Aspire Higher scholarship program recipients are:

 
  •   Undergraduate Scholar Awards  
  •  
    •   Sonia Goyal , Clarksville, Md. – The George Washington University  
    •  
    •   Anhthy Nguyen , Hayward, Calif. University of California, Los Angeles  
    •  
    •   Olivia Kenyon , West Chester, Pa. University of Florida  
    •  
  •   Graduate Scholar Awards  
  •  
    •   McKenzie White , Bakersfield, Calif. – Rocky Vista University College of Osteopathic Medicine
    •  
    •   Maria Rose Belding , Washington, D.C. Georgetown University School of Medicine  
    •  
    •   Brooke Abzug , Delray Beach, Fla. University of Florida : Department of Occupational Therapy
    •  
  •   Today's Woman Scholar Awards  
  •  
    •   Megan Gambino , Doylestown, Pa. – Delaware Valley University
    •  
    •   Hillary Hardin , North Bergen , N.J. – Felician University
    •  
    •   Sarah Ramirez , Humble, Texas Lake Erie College of Osteopathic Medicine (LECOM), Bradenton Campus
    •  

"Living with a skin condition can often be very difficult, especially when managing school – much of which was particularly challenging this year due to remote learning – and other activities. Thanks to the generosity of Ortho Dermatologics, I will be one step further toward achieving my goal of receiving a degree in Physical Therapy and Exercise Science," said Hillary Hardin , Felician University, North Bergen, N.J.  

 

To learn more about the Aspire Higher scholarship program and to see stories from previous scholarship recipients, please visit www.AspireHigherScholarships.com . The 2022 Aspire Higher scholarship program will be accepting applications in early 2022.

 

  About the Aspire Higher Scholarship Program
Since 2013, the Aspire Higher scholarship program has awarded 60 scholarships, providing students a total of $648,000 toward their higher education on campuses nationwide. The Aspire Higher scholarship program is now funded through the Bausch Foundation.

 

  About the Bausch Foundation
In 2017, the Bausch Foundation was established to improve the lives of patients globally by providing access to safe, effective medicines and by financially supporting health care education and causes. Since its inception, the Bausch Foundation has contributed millions of dollars worth of financial and product donations to global charitable health organizations.

 

  About Ortho Dermatologics
Ortho Dermatologics is one of the largest dermatology businesses dedicated to helping patients in the treatment of a range of therapeutic areas, including psoriasis, actinic keratosis, acne, atopic dermatitis and other dermatoses. In addition, the Ortho Dermatologics portfolio also includes several leading medical device systems for aesthetic applications, such as skin tightening and resurfacing, laser hair removal and other preventative therapeutic skin care treatments. More information can be found at www.ortho-dermatologics.com .

 

  About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn .

 

  Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch Health's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on Bausch Health, including but not limited to its project development timelines, and costs (which may increase). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

 

  Ortho Dermatologics is a trademark of Ortho Dermatologics' affiliated entities.
  © 2021 Ortho Dermatologics' affiliated entities.
ORD.0126.USA.21
 

 

  Bausch Health Investor Contact:
  Arthur Shannon  
arthur.shannon@bauschhealth.com  
(514) 865-3855
(877) 281-6642 (toll free)

 

  Bausch Health Media Contact:
  Lainie Keller  
lainie.keller@bauschhealth.com  
(908) 927-1198

 
 

  Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.) 

 
 

 

 
 

  (PRNewsfoto/Valeant Pharmaceuticals Interna) 

 
 

 Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/ortho-dermatologics-announces-2021-aspire-higher-scholarship-recipients-301343645.html  

 

SOURCE Bausch Health Companies Inc.

 
 

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Bausch Health Companies Inc.

Bausch Health Companies Inc.

Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.

illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less

Latest Press Releases

Related News

×